Medlife starts share buyback program
Romanian private healthcare group Medlife has started on Tuesday a share buyback program that was approved by shareholders in late 2024.
Romanian private healthcare group Medlife has started on Tuesday a share buyback program that was approved by shareholders in late 2024.
The purchase price will be €0.3375 per share, inclusive of dividend, subject to possible adjustments.
The financial results reported at the end of September show total assets of €43.5 million, revenues of €10.6 million, and a net profit of €2.5 million.
The company also seeks the approval of the election of the members of EVERGENT Investments' Board of Directors for a 4-year mandate, as well as the directors' remuneration policy.
The group will offer a maximum of 174,258,721 new shares to investors. The operation starts on June 3, 2024.
Four significant shareholders of One United Properties successfully sold 234,205,285 shares in the Company to local and international institutional investors.
The value of the company increased by 23% in the two years of its presence on the capital market, and at the time of the transfer it had a capitalization of RON 234.7 million.
Romania has officially joined the InvestEU Ukraine Export Credit Guarantee Facility, a joint initiative by the European Commission and the European Investment Fund (EIF).
The average net salary in Romania decreased by 2.5% to RON 5,508 (€1,109.91) in May, compared to April 2025, according to data from the National Institute of Statistics (INS).
The annual inflation rate in Romania rose to 5.7% in June 2025, up from 5.45% in May.
Romanian private healthcare network MedLife is investing €3 million in genetic testing and will launch a large-scale genetic testing program.
Romania's trade deficit rose by 16.4% in the first five months of this year compared to the same period last year, reaching €14.32 billion.